Asymchem Laboratories (002821) Stock Overview

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; information technology services; and pharmaceutical science and technology development activities, as well as sale, wholesale, and retail of drugs. In addition, it is involved in the manufacture, development, and sale of medicine raw materials and relevant products; manufacture of chemical products; and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.